West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026

The West Synchrony™ Prefillable Syringe (PFS) System offers strategic infrastructure to support Chinese biotech innovators to expand their global footprint in biologics and vaccines.

SHANGHAI, CHINA - Media OutReach Newswire - 16 June 2026 - West Pharmaceutical Services, Inc. (NYSE: WST), a long-standing partner to China's pharmaceutical industry, today announced the availability of its West Synchrony™ prefillable syringe (PFS) system to drug developers at CPHI & PMEC China 2026, taking place June 16-18, 2026. This innovative platform uniquely integrates the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier and emphasizes the company's commitment to supporting the development of China's biopharmaceutical sector in alignment with the country's 15th Five-Year Plan. By strengthening the innovation ecosystem and accelerating development and time to market, the company supports China's biopharmaceutical companies in achieving biotechnology breakthroughs and reaching global milestones.

Enabling China's Next Phase of Global Biopharmaceutical Growth

China's biopharmaceutical sector is entering a new phase of global relevance. Long recognized as a strategic pillar of the national economy, sustained policy support and investment over the past decade have helped build deep scientific capabilities and a rapidly maturing innovation ecosystem. As more biopharmaceutical companies "Go Global", many are establishing a growing international footprint, while others are accelerating their overseas ambitions. Emerging as core players on the global stage, Chinese companies accounted for nearly 50%¹ of all new drug molecules entering human trials in the first half of 2025 alone. At the same time, the growing complexity of biologics and vaccines is driving increased demand for advanced, high-quality drug delivery and packaging systems that can support product performance and safety from early development through commercialization. Competing globally also requires navigating stringent regulatory environments while ensuring reliable, scalable supply. Together, these factors make trusted partners with proven technical expertise and international regulatory experience critical for sustainable growth. To support Chinese biopharmaceutical companies in their ambitions, West has now made the West Synchrony™ PFS system available in the country.

West Synchrony™ PFS System

This gives Chinese innovators the infrastructure needed to compete on quality, safety, and regulatory compliance across international markets, with greater confidence and efficiency. "Chinese biopharmaceutical companies today have established themselves as serious global innovators, with significant opportunities to sustain momentum through high‑quality innovation," said Maha Guruswamy, Vice President & Managing Director, Commercial, Asia Pacific. "The challenge is that a traditional, individual-component system introduces significant technical and regulatory complexities. West Synchrony addresses these by providing a fully verified and integrated containment and delivery system from a single source, allowing our partners to accelerate development and focus on delivering therapies to patients."

Deepening A Long-Term Partnership with China's Pharmaceutical Ecosystem

The introduction of the West Synchrony™ PFS system reflects the company's decades-long commitment to supporting pharmaceutical innovation. This investment extends beyond product offerings to include technical expertise, regulatory support, and a single source of accountability that serve both domestic Chinese companies and multinational partners operating in China. "As China's biopharmaceutical companies continue to strengthen their capabilities and expand their presence globally, West is committed to partnering with them at every stage of their growth journey," said Philip Wang, Senior Director, Commercial, China. "We aim to enable them to achieve their global ambitions, and the West Synchrony™ PFS system is one example from our portfolio of high‑quality, innovative solutions that provide customers with the same trusted infrastructure relied upon by leading multinational pharmaceutical companies worldwide."

Join West at CPHI & PMEC China 2026

The West Synchrony™ PFS system will be showcased at CPHI & PMEC China 2026, where an expert from West will present on the role of integrated delivery systems in supporting China's next phase of biopharmaceutical innovation and its global ambitions for expansion. Trade media and industry stakeholders interested in learning more about the technology and its application in biologics are invited to visit the West booth during the exhibition. The details of the presentation are as follows:

Presentation: "Stop Piecing It Together—Get an Integrated Verified Prefillable Syringe System from One Source"

• Date & Time: June 17, 14:10-14:40

• Location: Shanghai New International Expo Center

• Speaker: Lynn Yao, Senior Manager, TCS, AP

The West Synchrony™ PFS System is now available to bio and pharmaceutical companies in China. Visit West at Booth N5D18 to learn more, or find out more information via the website here.

Forward-Looking Statements

Certain forward-looking statements are included in this press release. They use words and phrases such as "achieving biotechnology breakthroughs," "reaching global milestones," "accelerate development," and other similar terminology. These statements include, but are not limited to, statements regarding the anticipated benefits of the West Synchrony™ prefillable syringe system in China, the expected growth of China's bio-health and pharmaceutical industries, and West's ability to support customers' development and commercialization efforts. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this release. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in market conditions, regulatory requirements, global economic and geopolitical conditions, customer demand, supply chain constraints, competitive developments, technological changes, and other risks. These important factors are not all inclusive. For a description of certain additional factors that could cause West's future results to differ from those expressed in any such forward-looking statements, see Item 1A, entitled "Risk Factors," in West's Annual Report on Form 10-K for the year that ended on December 31, 2025. Except as required by law or regulation, West undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise.

¹ Goldman Sachs, "China Is Increasing Its Share of Global Drug Development", December 2025. https://www.goldmansachs.com/insights/articles/china-is-increasing-its-share-of-global-drug-development

Hashtag: #WestPharmaceuticalServices

The issuer is solely responsible for the content of this announcement.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support its customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, USA, West in its fiscal year 2025 generated USD 3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries in the United States and other jurisdictions, unless otherwise noted.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

West Pharmaceutical Services, Booth N5D18, CPHI & PMEC China 2026

BEIJING, CHINA – Media OutReach Newswire – 14 August 2026 – The "YOU BRING CHARM TO THE WORLD — The 18th Global Chinese Awards" came to a close at the Phoenix Center in Beijing on the evening of August 12.

On the evening of August 12, the "YOU BRING CHARM TO THE WORLD — The 18th Global Chinese Awards" concluded at the Phoenix Center in Beijing. The photo shows award recipients posing with presenters.

At this year's awards ceremony, Academician Zhang Boli of the Chinese Academy of Engineering received the Global Chinese Lifetime Achievement Award, while actress Sylvia Chang received the Global Chinese Special Tribute Award. Academician Pan Jianwei of the Chinese Academy of Sciences, Lu Chaoyang, Chair Professor at the University of Science and Technology of China, picture-book illustrator Cai Gao, Chinese freestyle skier Xu Mengtao, Gao Du, professor at the Beijing Dance Academy, and actress Xin Zhilei received the Global Chinese Award.

In his speech, Xu Wei, Chairman of the Board and CEO of Phoenix TV, said: "Each generation of Chinese people has its own responsibilities. The older generation worked hard with their roots in their homeland, while the younger generation embraces innovation and the world, becoming connectors between different cultures." Phoenix TV will continue to serve as an on-the-ground reporter of major global events, an international storyteller of Chinese culture, and a platform builder for international exchange, enabling audiences around the world to see more of the vibrant and diverse achievements of Chinese people.

The tribute section of the ceremony opened with an immersive children's picture-book theatrical performance based on classic works including The Story of the Peach Blossom Spring and Bao'er. Both works were created by Cai Gao, who received the Hans Christian Andersen Award for Illustration in April this year. During the ceremony, the host recalled the children's song Cai sang at the Andersen Award ceremony, prompting her to smile and sing "The Cuckoo" once again.

Upon receiving the Global Chinese Award, Cai Gao said that the splendid and outstanding artistic heritage of China has been a source of inspiration for her work, and that she has a deep love for the culture of this land. Seeing so many Chinese people achieve remarkable accomplishments in different fields has also given her spiritual strength. Quoting the phrase, "As long as life goes on, the struggle continues," she encouraged herself to keep creating with passion and curiosity. "Life and creation require dedication and perseverance. I am willing to devote myself to them, as I always have."

Joining the ceremony via video link, Lu Chaoyang shared his joy and said that the honor belongs to all Chinese researchers who have climbed, generation after generation, along the long and steep road of quantum science. Looking to the future, he offered this message: "The quantum world is very small, so small that it cannot be seen with the naked eye; but China's dreams in science and technology are immense. Through fundamental innovation, we should illuminate a farther future for human civilization."

In her acceptance speech, Xin Zhilei said she particularly liked the phrase "YOU BRING CHARM TO THE WORLD." "Everyone is a unique ray of light in this world. Through our efforts and down-to-earth dedication, we each make our own small contribution to the beauty of the world. As an actress, what I can do is put my heart into every role and bring to the world a little bit of the unique color that belongs to me." Lu Yang, director of Brotherhood of Blades II: The Infernal Battlefield, also sent his congratulations via video, expressing hope for continued collaboration and for the creation of more outstanding Chinese-language stories.

"If the dance steps of a people disappear, that chapter of history will also lose its voice." Over the past 50 years, Gao Du and his team have traveled across more than 20 provinces and autonomous regions throughout China, venturing deep into remote mountains and visiting people's courtyards and fireside gatherings. They learned from local communities dances that had no names, no stages and sometimes not even an audience, devoting themselves to the creation of the Chenxiang series.

Gao Du said he would continue dancing, both in the classroom and on larger stages, bringing folk dance traditions rooted in the land to the world and fostering dialogue among different cultures, so that the world can see the beauty of the East.

Wu Qingcai, Deputy Editor-in-Chief of China News Service, presented Xu Mengtao with the Global Chinese Award. Xu shared that August 13, 2026, marked exactly 24 years since she began competing in the aerials discipline of snow sports. She hopes everyone can create something extraordinary through perseverance and dedication. "In the future, I will once again stand on the starting platform and set off again. See you again at the summit."

As one of the creators of the song Tomorrow Will Be Better, Sylvia Chang said that she and fellow Chinese-language singers hope to use music to build a bridge for peaceful communication. She expressed gratitude for being able to continue pursuing a career she loves and for having a wonderful family. "I hope to share this gratitude and these blessings with everyone."

At the ceremony, the host recounted the eight-character motto that Academician Zhang Boli has followed throughout his life: "Uphold virtue to broaden its influence; use medical skills to serve humanity." Now approaching 80, Zhang Boli continues to see patients at a clinic every week. When patients have difficulty walking, he takes the initiative to go downstairs and see them in their cars.

Zhang Boli said that the concepts of traditional Chinese medicine—including health preservation, wellness and preventive treatment—represent one of the best practices of "proactive health management." Looking to the future with the compassion of a physician, he said: "Let traditional Chinese medicine benefit Chinese people around the world, and let traditional Chinese medicine benefit people everywhere. The world will be healthier because of traditional Chinese medicine."

It is reported that the "YOU BRING CHARM TO THE WORLD — Global Chinese Awards" was initiated by Phoenix Media Group in collaboration with China News Service and numerous Chinese-language media organizations in China and overseas. Together, they select and honor outstanding Chinese people who have achieved excellence and made a global impact in different fields, helping to amplify the achievements of exceptional Chinese individuals and inspire more generations to come.

Hashtag: #PhoenixTV

The issuer is solely responsible for the content of this announcement.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **